Abstract
Protective isolation is used in healthcare institutions for patients with increased susceptibility to infections, deliberately or not, like transplantations, cancer treatments, premature new-borns, extensive burns and other immune-impaired patients. Extensively treated intensive patients are also infection prone and extremely exposed to infections when placed in large bays with other patients. Since one out of three patients in hospitals has infections that may be transferred to others directly on the same room or indirectly via staff and equipment, it is important to take special care of the weakest patients that may have a poor ability to resist infections. Protective isolation is a very good, effective and economic alternative to hospital infections, increased length of stay and overuse of antibiotics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Andersen BM. Handbook of hygiene and infection control in hospitals. Part 1 microbiology and infection control. Bergen: Fagbokforlaget; 2014.
European Parliament and Council Directive 2000/54/EC of 18 September 2000 on the protection of workers from the risks related to exposure to biological agents at work.
Infectious Disease Act. Law 5 August 1994 no. 55 of protection against infectious diseases.
Regulations in infection control in health facilities - hospital infections, established by the Health and Social Affairs July 5, 1996 and July 17, 2005 pursuant to § 4–7 and § 7–11 of the Act on Aug. 5, 1994 no. 55 of protection against infectious diseases.
Action plan for infection control in Norwegian hospitals, Health Directorate’s Guidance series 2–92. Directorate of Health.
Use of isolation to prevent spread of infection in hospitals. Health Directorate’s Guidance series: Directorate of Health, Oslo; 1988: 2–88.
Health Personnel Act. Department of Health and Social Affairs. Act 1999-07-02 No. 64: 2001.
CDC Draft Guideline for Isolation Precautions in Hospital. Federal Register 59, 55552–55570, 1994 and 2004.
CDC. Draft guideline for isolation precautions in hospital. Fed Regist. 1994;59:55552–70. and 2004
Garner JS. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol. 1996;17:53–80.
Edmond M. Isolation. Infect Control Hosp Epidemiol. 1997;18:58–64.
CDC. Draft Guideline for preventing the transmission of Mycobacterium tuberculosis in health care facilities. Fed Regist. 1994;59:54242–303. and 2004; 69: 33034
Barlow G, Sachdev N, Nathwani D. The use of adult isolation facilities in a UK infectious disease unit. J Hosp Infect. 2002;50:127–32.
Damji S, Barlow GD, Patterson L, Nathwani D. An audit of the use of isolation facilities in a UK National Health Service trust. J Hosp Infect. 2005;60:213–7.
Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa: a systematic review of the literature. J Hosp Infect. 2006;64:7–15.
Hansen S, Stamm-Balderjahn S, Zuschneid I, et al. Closure of medical departments during nosocomial outbreak: data from systematic analysis of the literature. J Hosp Infect. 2007;65:348–53.
CDC. Management of multidrug-resistant organisms in healthcare settings, 2006. CDC. 2006: 1-72.
CDC. Prevention of transmission of multidrug resistant organisms 2009. CDC. 2009.
Siegel JD, Rhinehart E, Jackson M et al. 2007 guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. CDC. 2007.
Calfee DP, Salgado CD, Milstone AM, et al. Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014;35:772–96.
Pallin DJ, Camargo CA, Yoke DS, Schuur JD. Variability of contact precaution policies in US Emergency Departments. Infect Control Hosp Epidemiol. 2014;35:310–2.
Andersen BM. Isolation. In: Handbook of hygiene and infection control in hospitals. Oslo: Ullevål University Hospital; 2008. p. 216–48.
Andersen BM, Seljordslia B, Hochlin K, Rasch M, Syversen G. A predicted outbreak in an overcrowded, administratively neglected and run-down haemodialysis unit as an offer of “New Public Management” in Norwegian hospitals. J Hosp Admin. 2013;2:01.10.
Solvang G, Sandset PM, Fjellet AL, Brubakk O, Hochlin K, Solheim N, Andersen BM. Protective isolation. In: Handbook of hygiene and infection control for hospitals. Oslo: Ullevål University Hospital; 2003. p. 128–31.
Rikshospitalet: Daily work in protective isolation. 09/05/2005.
Rikshospitalet: for you to be a stem cell transplant. Guideline for adult patients and their families. 2006.
Marier RL. The design of isolation rooms. Infect Control Hosp Epidemiol. 1996;17:3–4.
Marena C, Zecca M, Carenini ML, Bruschi A, Bassi ML, Olivieri P, Azzaretti S, Locatelli F. Incidence of, and risk factors for, nosocomial infections among haematopoietic stem cell transplantation recipients, with impact on procedure-related mortality. Infect Control Hosp Epidemiol. 2001;22:510–7.
Salvigni S, Piva S. Ventilation systems for hospital rooms devoted two immune compromised and/or infectious patients. Proc Indoor Air. 1993;5:569–74.
Withington S, Chambers ST, Beard ME, et al. Invasive Aspergillosis in severely neutropenic patients over 18 years: impact of intranasal amphotericin B and HEPA filtration. J Hosp Infect. 1998;38:11–8.
Dykewicz CA. Hospital infection control in haematopoietic stem cell transplant recipients. Emerg Infect Dis. 2001;7:263–7.
Raad I, Hanna H, Osting C, Hachem R, Umphrey J, Tarrand J, Kantarjian H, Bodey GP. Masking of neutropenic patients transport from hospital rooms is associated with a decrease in nosocomial Aspergillosis during construction. Infect Control Hosp Epidemiol. 2002;23:41–3.
Gayet-Ageron A, Iten A, van Delden C, et al. In-hospital transfer is a risk factor for invasive filamentous fungal infection among hospitalized patients with haematological malignancies: a matched case-control study. Infect Control Hosp Epidemiol. 2015;36:320–8.
Wibbenmeyer L, Williams I, Ward M, et al. Risk factors for acquiring vancomycin-resistant Enterococcus and methicillin-resistant Staphylococcus aureus on a burn surgery step-down unit. J Burn Care Res. 2010;31:269–79.
Tuladhar E, Hazeleger WC, Koopmans M, Zwietring MH, Beumer RR, Duicer E. Residual viral and bacterial contamination of surfaces after cleaning and disinfection. Appl Environ Microbiol. 2012;78:7769–75.
Weber DJ, Rutala WA, Miller MB, Huslage K, Sickbert-Bennett E. Role of hospital surfaces in the transmission of emerging healthcare-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control. 2010;38:25–33.
Dancer SJ. Mopping up hospital infection. J Hosp Infect. 1999;43:85–100.
Andersen BM, Rasch M, Hochlin K, et al. Decontamination of rooms, medical equipment and ambulances, overusing a dry mist of hydrogen peroxide disinfectant. J Hosp Infect. 2006;62:149–55.
Andersen BM, Hochlin K, Daling JP. Cleaning and decontamination of reusable medical equipment, including the use of hydrogen peroxide dry-mist gas decontamination. J Microbial Biochem Technol. 2012;4:3–10.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Andersen, B.M. (2019). Protective Isolation. In: Prevention and Control of Infections in Hospitals. Springer, Cham. https://doi.org/10.1007/978-3-319-99921-0_20
Download citation
DOI: https://doi.org/10.1007/978-3-319-99921-0_20
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99920-3
Online ISBN: 978-3-319-99921-0
eBook Packages: MedicineMedicine (R0)